Mast Group is a pioneer in AST, with over 65 years of experience developing trusted, high-quality susceptibility testing products. Built on a legacy of innovation, quality, and collaboration with the pharmaceutical industry, Mast remains committed to advancing AST solutions that meet evolving clinical and regulatory demands.

Today, Mast offers a comprehensive and expanding range of AST products, including MASTDISCS^® AST, MASTRING-S^® and ADATAB^®. These manual testing solutions support susceptibility and MIC determination using disc diffusion and multipoint technology, in accordance with international standards such as Clinical and Laboratory Standards Institute (CLSI) and The European Committee on Antimicrobial Susceptibility Testing (EUCAST).